ArticleEFSA journal. European Food Safety Authority2025
The European Union summary report on surveillance for the presence of transmissible spongiform encephalopathies (TSE) in 2024.
Article in EFSA journal. European Food Safety Authority, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Possible alignment of the EU BSE surveillance with the new WOAH provisions.EFSA journal. European Food Safety Authority · 2026Article
- The European Union summary report on surveillance for the presence of transmissible spongiform encephalopathies (TSE) in 2024.EFSA journal. European Food Safety Authority · 2025Article
- The European Union summary report on surveillance for the presence of transmissible spongiform encephalopathies (TSE) in 2023.EFSA journal. European Food Safety Authority · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This report presents results of surveillance on transmissible spongiform encephalopathies in bovines, sheep, goats, cervids and other species, and genotyping in sheep and goats, carried out in 2024 by 27 EU Member States (EU27, MS), the UK (in respect of Northern Ireland, (XI)) and 8 non-EU reporting countries: Bosnia and Herzegovina, Iceland, Montenegro, North Macedonia, Norway, Serbia, Switzerland and Türkiye. In total, 980,624 bovines were tested by EU27 and XI (+3.4% compared to 2023), with 3 atypical bovine spongiform encephalopathy (BSE) cases reported (2 H-type: 1 in France, 1 in Ireland; 1 L-type in Poland); and 41,397 bovines by 8 non-EU reporting countries with no BSE cases reported. Four additional BSE cases were reported by the UK (1 classical and 1 H-type), the USA (1 L-type), Brazil (1 H-type). In total, 277,064 sheep were tested in EU27 and XI (-2.7% compared to 2023). In sheep, 458 scrapie cases were reported by 14 MS and XI: 380 classical scrapie (CS) by 6 MS (139 index cases (IC)) with genotypes of susceptible groups in 98.9% of the cases; 78 atypical scrapie (AS) (78 IC) by 13 MS. In non-EU reporting countries 25,337 sheep were tested, with Iceland reporting 61 CS and 2 AS cases, and Norway 9 AS cases. Random genotyping was reported by five MS and susceptible genotypes accounted for 7.8%. In goats, out of 93,960 tested (-8.5% compared to 2023), 71 cases of scrapie were reported, all from EU27 and XI: 65 CS (14 IC) by five MS and 6 AS (6 IC) by three MS. None of the genotyped cases in goats carried polymorphisms at codon 146 and 222. In total, 1761 cervids were tested for chronic wasting disease by 9 MS, none tested positive. Norway tested 10,932 cervids with 2 European moose positive, Serbia tested 186 animals and Iceland 96 animals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.